Michelle Goldsmith

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Alloy Ventures, Inc. is an independent Venture Capital firm founded in 1984 by Craig C. Taylor, John F. Shoch and Tony Di Bona. The firm is headquartered in Palo Alto, California.

Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom.

St. Jude Medical Systems AB develops, manufactures, and markets medical devices. It offers intravascular sensors to measure blood pressure in the coronary arteries for the calculation of fraction flow reserve, hemostasis management systems to stop arterial bleeding, and interventional radiology devices used in radiology interventions. The company distributes products through distributors in the United States, the United Kingdom, Germany, France, Benelux, Switzerland, Japan, Australia, and Thailand. It was founded in 1988 and is located in Uppsala, Sweden.

Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia.

Australian Investment Council is an Australian private company located in Sydney. The firm operates as an association. Navleen Prasad has been the CEO since 2022.

Medical Research Commercialisation Fund Trust invests in life science companies located in Australia. The fund focuses on companies operating in the fields of medical research institutes and allied research hospitals. It provides seed and early stage financing in project investment of up to $0.02 million, at the stage of company formation invests up to $4 million and also makes follow-on investments of up to $2 million. It seeks co-investment with other investors for technologies with larger capital requirements.

QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA.

Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia.

Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel.

Baker Heart & Diabetes Institute owns and operates a medical research institute. The company is headquartered in Melbourne, Australia.

OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia.

Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

Abbott Medical Japan Co., Ltd. develops markets and distributes medical devices. The company was founded on June 26, 1987 and is headquartered in Tokyo, Japan.

Coala-Life AB develops a medical device that connects the person's heart to the cloud, for remote screening and monitoring of heart and lungs. The company was founded by Philip Axel Wilhelm Siberg, Magnus Samuelsson and Ulf Roger Tossman on April 15, 2004 and is headquartered in Stockholm, Sweden.

Part of Abbott Laboratories, St. Jude Medical AB is a company that manufactures and distributes medical devices. The company is based in Stockholm, Sweden and was founded in 1994.

Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ.

Medicover GmbH is a German medical company that specializes in internal medicine, endocrinology, diabetology, andrology, and infectious diseases. The private company is based in Berlin, Germany. The company has specialized medical centers that provide healthcare services to patients throughout Germany. The company was founded in 1995 and is led by CEOs Sven Diederich and Kristian Koch.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA.

Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA.

Part of Danaher Corp., Leica Biosystems Nussloch GmbH is a leader in workflow solutions and automation, integrating each step in the workflow from biopsy to diagnosis. The company is based in Nussloch, Germany. Leica Biosystems has Novocastra reagents & antibodies to deliver superior IHC & ISH staining solutions, which pathologists can rely on. The German company provides VISION24 resources and rotary microtomes to give skilled microtomists the precision, control, and comfort they need to get the best from every block.

University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL.

Health Market Science, Inc. is supplier of provider data and end-to-end solutions that address data management, regulatory compliance and market intelligence challenges. Its solutions include CompleteView, data assessment services, data integration and enrichment services, data remediation services, Expense Manager, prescriber remediation services, Prescriber Eligibility, Provider MasterFile, Provider Online, MarketView, web services and Provider MasterFile for CRM. The firm helps healthcare organizations solve business challenges centered on healthcare provider information. The company uses big data technology and domain expertise to help its clients comply with evolving federal and state laws, reduce operational costs and maximize market opportunities. Health Market Science offers robust solutions based on the most comprehensive provider database, including healthcare providers, healthcare organizations and their affiliations, coupled with the largest medical claims database in the U.S. The company was founded in 1999 by Mark Brosso and is headquartered in King of Prussia, PA.

Icellate Medical AB provides cancer profiling for precision oncology. The company is based in Solna, Sweden. The Swedish company develops tools for clinical decision making to help healthcare providers make informed decisions for their patients. The company was founded in 2011. Erik Pär Pelle Redare has been the CEO of the company since 2014.

Part of Nilfisk Holding A/S, Nilfisk, Inc. (Japan) is a Japanese company that manufactures and wholesales floor cleaning machinery equipment.

PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia.

Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia.

Siluria Technologies, Inc. develops and manufactures a direct chemical process for plastics and fuels from natural gas. Its second process technology can convert ethylene to liquid fuels such as gasoline, diesel or jet fuel. The firm’s revolutionary catalyst technologies uniquely combine nanomaterials, biotechnology and chemical engineering, to convert an abundant, ubiquitous, and inexpensive feedstock into high value, drop-in fuels and chemicals using processes that can be seamlessly integrated into existing industry infrastructure. The company was founded by Clinton Whitewood Bybee and Alexander Tkachenko in 2007 and is headquartered in San Francisco, CA.